- The Nasdaq closed 0.25% lower on Thursday at 15,248.
- Moderna jumped 7% on news of a two-in-one vaccine for COVID & the flu.
- LuluLemon soared 10% to a fresh record high on impressive Q2 results.
The US markets closed lower again on Thursday as investor concerns over the economic impact of the spreading Delta COVID-19 variant weighed the markets down.
The Dow Jones fell 0.43% to finish the trading day down 152 points to close at 34,879 points.
The tech heavy NASDAQ fell 0.25% to finish the trading day down 38 points to close at 15,248 points.
One bitcoin is worth US$46,300 going into the Asian trading day.
The Australian dollar is stronger against the major currencies and is buying 73.69 US cents.
Biotech giant Moderna jumped more than 7% yesterday after the company announced it is working on an advanced two-in-one vaccine booster for protecting against COVID-19 and the seasonal flu. The company is calling the new vaccine mRNA-1073 and it combines the company?s COVID-19 vaccine with a flu shot that?s also being developed.
Shares in LuluLemon soared more than 10% to a fresh record high on Thursday after the athletic apparel giant released second quarter results that topped all expectations. For the period, LuluLemon reported an EPS of US$1.65/share, higher than the expected US$1.19/share, revenue of US$1.45bn, exceeding the estimated US$1.34bn, and North America sales jumped 63% YoY. LuluLemon increased its full-year guidance for both revenue and earnings.
And Facebook has revealed its smart glasses product, the #RayBanStories, in partnership with Ray-Ban to capture, share and listen at any time using wearable smart glasses.